Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2001

View Archived Issues

MMP inhibition with batimastat reduces inflammation in experimental colitis

First case of linezolid-resistant Staphylococcus aureus infection reported

HIV protease inhibitors associated with lipoprotein alterations and endothelial dysfunction

Novel glycoalkaloid tomatine has potential as adjuvant in malaria vaccine development

Phogen signs licensing agreement with Genencor for VP22 technology

Avigen begins second phase I trial with Coagulin-B

FDA approves combination antihistamine/decongestant Zyrtec-D

Two antiangiogenesis agents from EntreMed receive orphan drug status

Phase II study of CETi-1 cholesterol vaccine from Avant initiated

E.C. clears Resovist via mutual recognition procedure

RenaGel receives marketing approval in Brazil

Active Biotech signs letter of intent with Avidex

Schwarz updates clinical trial programs

Optison product rights agreement amended

Praecis announces meeting date with FDA regarding Plenaxis NDA

Corixa and GSK submit complete response to FDA for Bexxar

Specific PPARgamma antagonist gives insight into receptor's role in adipogenesis

Roche discloses antiproliferative derivatives useful for the treatment of solid tumors

CRF receptor antagonists reported by researchers at Eisai

Schering-Plough identifies novel selective NK1 receptor antagonists

Grelan designs new series of PDE4 inhibitors

NPY5 receptor antagonists from Schering-Plough may be useful for treating obesity and diabetes

Natrecor launch quickly follows first approval in U.S.

Synthetic vitamin D3, ED-71, significantly increases BMD, BMC and bone strength

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...